We’re continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.
Vadim Gladyshev of Harvard Medical School discussed methods of discovering longevity interventions, including analyzing the genomes of long-lived mammals and identifying organ-specific changes. He also discussed using epigenetic clocks along with data-driven methods and animal studies that determine the value of potential new compounds and multiple, combined interventions.
Write a comment: